This exciting new programme has been introduced as a spin-off from the very successful Drug Discovery MSc in response to the increasing opportunities which now exist for research scientists who can evaluate the business potential of their science as well as generate the science itself.
This MSc contains the science core of the Pharmaceutics MSc and combines a broad overview of the drug discovery and development process with specialisation in management training and awareness, and strategic partnering and business development skills.
Students undertake modules to the value of 180 credits.
The programme consists of four core modules (120 credits), and a dissertation (60 credits).
All students undertake a business development project based on an aspect of science from drug discovery either at the UCL School of Pharmacy or in industry.
Teaching and learning
The programme is delivered through a combination of lectures, tutorials and seminars and practical classes. Assessment is through a combination of written examination and coursework. The business development project is by written report and oral presentation to the class and a judging panel of scientists and managers.
Further information on modules and degree structure is available on the department website: Drug Discovery and Pharma Management MSc
Students who complete the Drug Discovery and Pharma Management MSc will progress to careers in the various aspects of the pharmaceutical and biotechnology industries including research, product development and manufacturing, clinical trials and regulatory affairs.
Recent career destinations for this degree
Careers data is taken from the ‘Destinations of Leavers from Higher Education’ survey undertaken by HESA looking at the destinations of UK and EU students in the 2013–2015 graduating cohorts six months after graduation.
The Pharma Management component of this MSc is led by Dr Nigel Ratcliffe, formerly Vice-President for regulatory and commercial affairs at Astra Zeneca.
Students visit a leading research laboratory e.g. GlaxoSmithKline to look at computer-based molecular modelling, how physico-chemical properties are determined, the robotic compound library, and high throughput screening. The visit is supplemented by material and instruction and the discovery process of a drug will be worked through in detail.
Students attend a one-day research conference on an aspect of drug discovery and development organised by the Society for Medicines Research where there is opportunity to interact with leading industrialists and researchers in the field.
The Research Excellence Framework, or REF, is the system for assessing the quality of research in UK higher education institutions. The 2014 REF was carried out by the UK's higher education funding bodies, and the results used to allocate research funding from 2015/16.
The following REF score was awarded to the department: School of Pharmacy
87% rated 4* (‘world-leading’) or 3* (‘internationally excellent’)
Learn more about the scope of UCL's research, and browse case studies, on our Research Impact website.
Visit the Drug Discovery and Pharma Management (MSc) page on the University College London website for more details!